Submission Details
| 510(k) Number | K150868 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2015 |
| Decision Date | June 23, 2015 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K150868 is an FDA 510(k) clearance for the Solana GAS Assay, Solana instrument, a Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System (Class II — Special Controls, product code PGX), submitted by Quidel Corporation (Athens, US). The FDA issued a Cleared decision on June 23, 2015, 83 days after receiving the submission on April 1, 2015. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.2680.
| 510(k) Number | K150868 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2015 |
| Decision Date | June 23, 2015 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PGX — Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.2680 |
| Definition | An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients. |